Compare IAF & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IAF | MBOT |
|---|---|---|
| Founded | 1985 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.7M | 114.9M |
| IPO Year | N/A | 2000 |
| Metric | IAF | MBOT |
|---|---|---|
| Price | $12.29 | $1.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 20.6K | ★ 1.1M |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | ★ 11.44% | N/A |
| EPS Growth | N/A | ★ 60.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $119.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.36 | $1.60 |
| 52 Week High | $14.54 | $4.62 |
| Indicator | IAF | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 44.21 | 42.92 |
| Support Level | $11.88 | $1.65 |
| Resistance Level | $13.21 | $2.21 |
| Average True Range (ATR) | 0.24 | 0.08 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 23.75 | 28.12 |
Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.